TapewireFind a company

organization · Reporting owner

Accelmed Partners II L.P.

Disclosed activity across 2 companies

Tapewire entity
117098
SEC CIK
0001807256

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MINERVA SURGICAL INCUTRS · Entity 11556410% ownerFebruary 09, 2023February 09, 2023
NeuroPace IncNPCE · Entity 545910% ownerNovember 21, 2022November 23, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MINERVA SURGICAL INC

Report date February 09, 2023 · Filed February 09, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect122,189,638 Reported balance Holding disclosure · report date 2023-02-09 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 122,189,638

F1: Shares are held by Accelmed Partners II L.P. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP L.P., which is the general partner of Accelmed Partners II L.P. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II L.P. Dr. Geiger, a member Minerva Surgical, Inc.'s board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP L.P., Accelmed Partners II L.P. and Dr. Geiger is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Filing footnotes · ownership attribution and instrument terms

F1: Shares are held by Accelmed Partners II L.P. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP L.P., which is the general partner of Accelmed Partners II L.P. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II L.P. Dr. Geiger, a member Minerva Surgical, Inc.'s board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP L.P., Accelmed Partners II L.P. and Dr. Geiger is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

NeuroPace Inc

Report date November 21, 2022 · Filed November 23, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect4,370,550 Reported balance After 2022-11-21 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2022-11-21 · Purchase · Acquired 327,893 · Balance 4,370,550

F1: Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Common StockSEC Table I · non-derivativeDirect4,432,948 Reported balance After 2022-11-22 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2022-11-22 · Purchase · Acquired 62,398 · Balance 4,432,948

Filing footnotes · ownership attribution and instrument terms

F1: Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 22, 2022 Filed Nov 23, 2022 17:29 UTC NeuroPace Inc NPCE · Entity 5459 PurchaseCommon Stock 62,398 $1.50 $93,534.60
Disclosure

SEC source: 0000899243-22-036949 · doc4.xml · nonDerivative · entry 2

Accelmed Partners II L.P. · CIK 0001807256 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,432,948

Read SEC document
November 21, 2022 Filed Nov 23, 2022 17:29 UTC NeuroPace Inc NPCE · Entity 5459 PurchaseCommon Stock 327,893 $1.50 $491,511.61
Disclosure

SEC source: 0000899243-22-036949 · doc4.xml · nonDerivative · entry 1

Accelmed Partners II L.P. · CIK 0001807256 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,370,550

F1 · ownership.direct: Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Read SEC document
April 26, 2021 Filed Apr 26, 2021 17:18 UTC NeuroPace Inc NPCE · Entity 5459 ConversionSeries B' Preferred Stock · Derivative 3,454,422 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-028327 · doc4.xml · derivative · entry 2

Accelmed Partners II L.P. · CIK 0001807256 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,454,422

Underlying: Common Stock · 3,454,422 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.

F1 · ownership.direct: Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Read SEC document
April 26, 2021 Filed Apr 26, 2021 17:18 UTC NeuroPace Inc NPCE · Entity 5459 ConversionCommon Stock 3,454,422 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-028327 · doc4.xml · nonDerivative · entry 1

Accelmed Partners II L.P. · CIK 0001807256 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,042,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:44 UTC NeuroPace Inc NPCE · Entity 5459 PurchaseCommon Stock 588,235 $17.00 $9,999,995.00
Disclosure

SEC source: 0001209191-21-028192 · doc4.xml · nonDerivative · entry 1

Accelmed Partners II L.P. · CIK 0001807256 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 588,235

F1 · shares: Reflects shares purchased from the underwriters in the Companys initial public offering.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.